Indeed, elevated IL-6 levels, which correlate with COVID-19 severity (Aziz et al., 2020; Frontera et al., 2020, 2021; Pairo-Castineira et al., 2021; Zhu et al., 2021), have been associated with depression and alterations in activity in the subgenual cingulate cortex (Drevets et al., 2008; Harrison et al., 2009). Here, IL6 is linked to depressive symptom measurement.